Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03901014 · ClinicalTrials.gov registry record · NA
Investigating the Production of Lipoproteins and Acetyl-CoA During a Ketogenic Diet
A NA study of Cholesterol Metabolism and Ketone Metabolism, sponsored by Touro University, California.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
- 1
- Study location
NCT03901014 is a NA study of Cholesterol Metabolism and Ketone Metabolism that has completed, run by Touro University, California. The registered enrollment target is 4 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03901014, a NA study of Cholesterol Metabolism and Ketone Metabolism, has completed, sponsored by Touro University, California.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to understand how the reduction in dietary carbohydrates in a very-low carbohydrate ketogenic diet impacts the synthesis of cholesterol, fatty acid, and ketones, and the turnover rate of VLDL and chylomicron particles.
Conditions Studied
Interventions
- OTHER Very low carbohydrate diet
- OTHER Standard American diet
Study Locations (1)
California
- Touro University California - Vallejo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2019-03-31 |
| Est. Completion | 2019-04-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03901014
The ClinicalTrials.gov registry entry for NCT03901014 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Touro University, California, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cholesterol Metabolism appearing as the primary indexed condition, and to 2 interventions - of which Very low carbohydrate diet is the first listed.
NCT03901014 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03901014 about?
NCT03901014 is a clinical study titled "Investigating the Production of Lipoproteins and Acetyl-CoA During a Ketogenic Diet". The purpose of this study is to understand how the reduction in dietary carbohydrates in a very-low carbohydrate ketogenic diet impacts the synthesis of cholesterol, fatty acid, and ketones, and the turnover rate of VLDL and chylomicron particles.
What is the current status of trial NCT03901014?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2019-03-31. Estimated completion is 2019-04-18.
What conditions does trial NCT03901014 study?
This clinical trial studies the following conditions: Cholesterol Metabolism, Ketone Metabolism.
What interventions are being tested in trial NCT03901014?
The interventions under investigation include: Very low carbohydrate diet (OTHER), Standard American diet (OTHER).
Who is sponsoring clinical trial NCT03901014?
This trial is sponsored by Touro University, California, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03901014 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cholesterol Metabolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.